Biomedical Applications of Graphene by Shen, He et al.
Theranostics 2012, 2(3) 
 
 
http://www.thno.org 
283 
T Th he er ra an no os st ti ic cs s   
2012; 2(3):283-294. doi: 10.7150/thno.3642 
Review 
Biomedical Applications of Graphene 
He Shen1, Liming Zhang1,2, Min Liu1, and Zhijun Zhang1  
1.  Division of Nanobiomedicine, Suzhou Institute of Nano-tech and Nano-bionics, Chinese Academy of Sciences, 398 
Ruoshui Road, Suzhou, 215123, China; 
2.  Hunan Key Laboratory of Green Packaging and Application of Biological Nanotechnology, Hunan University of Tech-
nology, Zhuzhou 412008, China.  
  Corresponding  author:  Professor  Zhijun  Zhang,  Division  of  Nanobiomedicine,  Suzhou  Institute  of  Nano-tech  and 
Nano-bionics,  Chinese  Academy  of  Sciences,  398  Ruoshui  Road,  Suzhou,  215123,  China.  Tel:  86-512-62872556;  Fax: 
86-512-62603079; E-mail: zjzhang2007@sinano.ac.cn 
© Ivyspring International Publisher. This is an open-access article distributed under the terms of the Creative Commons License (http://creativecommons.org/ 
licenses/by-nc-nd/3.0/). Reproduction is permitted for personal, noncommercial use, provided that the article is in whole, unmodified, and properly cited. 
Received: 2011.10.15; Accepted: 2011.11.16; Published: 2012.03.05 
Abstract 
Graphene exhibits unique 2-D structure and exceptional phyiscal and chemical properties 
that lead to many potential applications. Among various applications, biomedical applications 
of graphene have attracted ever-increasing interests over the last three years. In this review, 
we present an overview of current advances in applications of graphene in biomedicine with 
focus on drug delivery, cancer therapy and biological imaging, together with a brief discussion 
on the challenges and perspectives for future research in this field. 
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Introduction 
Graphene,  a  novel  two-dimensional  nano-
material composed of sp2-bonded carbon atoms, pos-
sesses a number of extraordinary  electronic, optical, 
thermal  and  mechanical  properties  [1-5].  With  the 
rapid  deveolopment  of  synthesis  and  functionaliza-
tion approches, graphene and its related derivatives 
have  shown  outstanding  potentials  in  many  fields, 
such  as  nanoelectronics  [6],  composite  materials 
[7-11], energy technology (for examples, fuel cell, su-
percapacitor, hydrogen storage) [12-14], sensors [15], 
and catalysis [16], which have been summarised by 
several review articles [17-21].  
Beyond  the  applications  aforementioned,  the 
biomedical application of graphene is a relative new 
area with significant potential. Since the seminal re-
port  on  use  of  graphene  oxide  (GO)  as  an  efficient 
nanocarrier for drug delivery by Dai et al. [22] in 2008, 
the  first  study  on  graphene  for  biomedical  applica-
tions, a lot of interesting work has been carried out to 
explore the use of graphene for widespread biomedi-
cal  applications,  ranging  from  drug/gene  delivery, 
biological sensing and imaging, antibacterial materi-
als, to biocompatible scaffold for cell culture. The in-
tensive research on the bioapplications of graphene 
and its derivatives is due to many fascinating proper-
ties, such as high specific surface area (2630 m2/g), 
exceptional eletronic conductivity (mobility of charge 
carriers,  200,000  cm2  V-1  s-1),  thermal  conductivity 
(~5000  W/m/K),  mechanical  strength  (Young’s 
modulus, ~1100 Gpa) of graphene, and, intrinsic bio-
compatibility, low cost and scalable production, and 
facile  biological/chemical  functionalization  of  GO 
[20,21]. 
The exciting achievements obtained in the last 3 
years have been reviewed by Liu et al. [17,23], Li, Lin 
and coworkers [18], and Jiang [20]. Therefore we do 
not intend to give a systematic and detailed review on 
this topic, instead, we will give a brief overview of 
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recent  work  that  is  updated  and  complementary  to 
those described in the reviews mentioned above.  
2. Drug/Gene Delivery and Cancer Therapy 
2.1 Drug delivery 
GO, produced by vigorous oxidation of graphite 
by Hummers method [24], is an ideal nanocarrier for 
efficient drug and gene delivery. GO used for drug 
delivery is usually 1-3 layers (1-2 nm thick), with size 
ranging from a few nanometers to several hundred 
nanometers [19,25,26]. The unique structural features, 
such as large and planar sp2 hybridized carbon do-
main, high specific surface area (2630 m2/g), and en-
riched  oxygen-containing  groups,  render  GO  excel-
lent biocompatibility, and physiological solubility and 
stability, and capability of loading of drugs or genes 
via chemical conjugation or physisorption approach-
es. Moreover, the reactive COOH and OH groups GO 
bears facilitate conjugation with various systems, such 
as  polymers  [27],  biomolecules  (biotargeting  ligand 
[26], DNA [28], protein [29-31]), quantum dots [32], 
Fe3O4 nanoparticles [33], and others [34]), imparting 
GO  with  multi-functionalities  and  multi-modalities 
for diverse biological and medical applications.  
Inspired  by  the  ideas  for  carbon  nano-
tubes-based  drug  delivery  [23,35-39],  Dai  et  al.  ex-
plored  for  the  first  time  nanoscale  GO  (NGO)  as  a 
novel and efficient nanocarrier for delivery of water 
insoluble aromatic anticancer drugs into cells [22]. In 
their  approach,  NGO  was  first  conjugated  with  an 
amine-terminated  six  armed  polyethylene  glycol 
(PEG) molecule, followed by loading of a water in-
soluble anticancer drug, SN38 onto NGO surface by 
simple non-covalent adsorption via π-π stacking. The 
PEG-functionalized NGO loaded with SN38 exhibited 
high  cytotoxicity  for  HCT-116  cells,  1000-fold  more 
potent than CPT-11. In another work, the same group 
studied targeted delivery of chemical drugs into cells 
by  using  a  Rituxan  (CD20+  antibody)  conjugated 
NGO-PEG [26] (Figure 1). This work further demon-
strated that the drug release from the GO surface was 
pH  dependent,  suggesting  the  possibility  of 
pH-controlled  drug  release.  The  pH-sensitive  drug 
release behavior from many different GO-based drug 
delivery systems was also studied later by Chen et al. 
[40], Shi and colleagues [9], Misra et al. [41], and our 
group  [42].  Apart  from  pH-activated  drug  release, 
recently  Pan  and  colleagues  [43]  developed  a  ther-
mo-responsive  drug  delivery  cargo, 
poly(N-isopropylacrylamide)  grafted  graphene 
sheets. 
Combined  use  of  multiple  drugs  is  a  widely 
adopted  clinical  practice  in  cancer  therapy  to  over-
come drug resistance of cancer cells [44,45]. However, 
few  reports  on  nanomaterial-based  drug  delivery 
systems for controlled loading and delivery of multi-
ple drugs can be found in the literature due to tech-
nical difficulties. To address this issue, our group [42] 
explored  the  feasibility  of  GO  as  a  nanocarrier  for 
controlled  loading  and  targeted  delivery  of  mixed 
chemical drugs. In our approach, folic acid and SO3H 
groups  conjugated  GO  was  co-loaded  with  two 
chemical drugs, doxorubicin (DOX) and camptothecin 
(CPT) via π-π stacking in  a controlled way.  We re-
vealed that combined loading of the two drugs by GO 
with folic acid ligand exhibits specific targeting and 
much  higher  cytotoxicity  to  MCF-7  cells,  human 
breast cancer cells with folic acid receptors, and more 
importantly, remarkably higher cytotoxicity than that 
loaded with only one drug.  
 
 
 
Figure 1. A. Schematic illustration of DOX loading onto NGO-PEG conjugated with anti-CD20 antibody; B. In vitro cytotoxicity at 
different DOX concentration showing targeted delivery of DOX into specific cells. C. NIR fluorescence image of targeted cells treated 
with the NGO-PEG of Rituxan.[26] © 2008. Reproduced with kind permission from Springer Science+Business Media and Tsinghua Press. 
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The exploration of GO-based drug delivery ex-
pands  from  anticancer  drugs  to  other  drugs  for 
non-cancer diseases treatment. Most recently, Rana et 
al. [46] reported the delivery of an anti-inflammatory 
drug, Ibuprofen, by using a chitosan-grafted GO. In 
this  case,  the  loading  rate  of  Ibuprofen  on  the  GO 
sheet  was  determined  to  be  9.7%.  Furthermore,  the 
work demonstrates that controlled drug release can be 
achieved by adjustment of pH value. 
To enhance the anticancer effect, Yang and col-
leagues [47] designed and prepared a magnetic- and 
bio-  dual  targeting  drug  delivery  cargo  based  on 
GO-Fe3O4  nanoparticle  hybrid.  The  in  vitro  experi-
ments  indicated  specific  targeting  of  the  multifunc-
tional drug carriers by SK3 human breast cancer cells. 
Clearly,  in vivo study  is desired to demonstrate the 
performance  of  this  external  magnetic  field-guided 
and bio-targeted drug delivery system.  
2.2 Gene delivery 
Gene therapy is a novel and promising approach 
to treat various diseases caused by genetic disorders, 
including  cystic  ﬁbrosis,  Parkinson’s  disease,  and 
cancer [48]. Successful gene therapy requires a gene 
vector that protects DNA from nuclease degradation 
and  facilitates  cellular  uptake  of  DNA  with  high 
transfection efficiency [49]. The major challenge facing 
the development of gene therapy is lack of efficient 
and safe gene vectors [50]. Recently Liu et al. [51] and 
our group [52] studied gene delivery using polyeth-
ylenimine  (PEI)-modified  GO  (PEI-GO),  the  proce-
dure of which is shown in Figure 2A. GO conjugated 
with positively charged PEI allows  condensation  of 
plasmid DNA onto the surface of GO sheet through 
electrostatic  interaction  arising  from  the  cationic 
polymer. Liu and colleagues [51] examined the trans-
fection  efficiency  of  GO-PEI-10K  and  GO-PEI-1.2K 
and compared with the unbound polymers PEI-10K 
and  PEI-1.2K,  respectively,  as  shown  in  Figure  2B. 
Their experiment indicates that grafting PEI to GO not 
only significantly lowered the cytotoxicity of the cat-
ionic  polymer,  but  also  improved  the  transfection 
efficiency of the polymer. We also found much higher 
luciferase  expression  in  HeLa  cells  with 
PEI-GO/pGL-3 complexes (2.75 × 109 RLU/mg pro-
tein ) than that of PEI/pGL-3 complexes (2.07 × 109), 
and high DNA transfection efficiency by PEI-GO in 
HeLa cells even in the presence of 10% FBS [52]. This 
observation  is  somewhat  surprising  since  PEI  is 
widely  used  in  gene  transfection  due  to  its  high 
transfection  efficiency,  PEI  grafted  to  other  systems 
usually  leads  to  inevitable  decrease  in  transfection 
efficiency.  And,  serum  protein  can  hinder  cellular 
uptake, and therefore often reduces the transfection 
efficiency [52]. Much work has to be done to under-
stand the phenomenon. All together, the findings by 
Liu and us suggest that PEI-GO is a promising can-
didate for efficient gene delivery. 
 
 
Figure 2. A. Schematic illustration of synthesizing GO-PEI-DNA complexes via electrostatic interactions. B. Confocal fluorescence 
images of EGFP transfected HeLa cells using PEI-1.2k (a), GO-PEI-1.2k (b), PEI-10k (c), and GO-PEI-10k (d) at different N/P ratios from 10 
to 80. [51] Reproduced by permission of The Royal Society of Chemistry. 
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Most recently a research group from Singapore 
[53] reported synthesis of chitosan-functionalized GO 
(GO-CS) sheets and their application for drug/gene 
delivery. This work shows that GO-CS sheets have a 
high drug payload, and the CPT-loaded GO-CS ex-
hibits better cancer cell killing ability than the pure 
CPT.  At  the  same  time,  GO-CS  could  condense 
plasmd DNA into stable nanoparticles, which show 
reasonable DNA transfection efficiency in HeLa cells 
at certain nitrogen/phosphate ratio. Further work on 
simultaneous loading and delivery of chemical drug 
and  gene  by  the  GO-CS  nanocarrier  for  combined 
chemo- and gene- therapy is highly desired, to gain an 
enhanced therapeutic efficacy.  
Our group studied sequential delivery of DOX 
and  Bcl-2  targeted  siRNA  to  HeLa  cells  using  a 
PEI-GO nanocarrier [54] (Figure 3). Briefly, HeLa cells 
were  first  incubated  with  the  GO-PEI  loaded  with 
Bcl-2 targeted siRNA for 5h, and the incubation was 
continued for another 43 h after the fresh medium was 
replaced.  The  cells  were  then  treated  with 
DOX-loaded  PEI-GO  complexes  for  24  h.  The  cyto-
toxicity assay reveals that the PEI-GO/Bcl-2 targeted 
siRNA  complexes  dramatically  enhanced  the  cyto-
toxicity  of  the  PEI-GO/DOX,  compared  to  the 
PEI-GO/scrambled  siRNA  complexes,  as  evidenced 
by remarkable decrease in IC50
 
of DOX, due to strong 
synergistic anti-cancer effect of the PEI-GO/DOX and 
PEI-GO/Bcl-2 targeted siRNA. 
 
Figure 3. A. Scheme showing sequential delivery of siRNA and anticancer drugs by PEI-GO. B. Relative viability of HeLa cells treated 
with (1) PEI-GO/Bcl-2 targeted siRNA, and (2) PEI-GO/scrambled siRNA, followed by incubation with PEI-GO/DOX. C. IC50 of DOX for 
the HeLa cells sequentially incubated with (1) PEI-GO/Bcl-2 targeted siRNA and PEI-GO/DOX, and (2) PEI-GO/scrambled siRNA and 
PEI-GO/DOX.  The  result  indicates  that  PEI-GO/Bcl-2-targeted  siRNA  complexes  significantly  enhanced  the  cytotoxicity  of  the 
PEI-GO/DOX. [54] Copyright Wiley-VCH Verlag GmbH & Co. KGaA. Reproduced with permission. 
 
 
2.3. Cancer Therapy 
Much success has been made on exploration of 
graphene in drug delivery by in vitro test, as we dis-
cussed  above.  For  clinical  cancer  and  other  disease 
treatment, the in vivo behavior of graphene loaded 
with drugs must be investigated. Liu and colleagues 
[55] for the first time studied in vivo tumor uptake 
and photothermal therapy with PEGylated GO using 
xenograft tumor mouse models. They observed very 
high tumor uptake of the PEG-modified GO due to 
highly efficient tumor passive targeting of GO caused 
by  EPR  effect.  Moreover,  under  the  low-power 
near-infrared (NIR) laser irradiation on the tumor, a 
highly efficient tumor destruction was achieved, tak-
ing the use of strong absorbance of GO in the  NIR 
region (Figure 4). Theranostics 2012, 2(3) 
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Figure 4. A. Schematic illustration of PEG functionalized NGS and labeled by Cy7. B. Photos of tumors on mice after various treatments 
indicated. The laser irradiated tumor on NGS injected mouse was completely destructed.[55] Reprinted with permission from ref.55. 
Copyright 2010 American Chemical Society. 
 
 
Later, Markovic et al. [56] compared the photo-
thermal anticancer activity of NIR-excited graphene 
and  carbon  nanotubes.  Despite  of  its  lower 
NIR-absorbing capacity, polyvinylpyrrolidone-coated 
graphene nanoparticles display higher photothermal 
responsiveness,  and  induce  more  photothermal  cell 
death because of oxidative stress and mitochondrial 
depolarization  and  caspase  activation  leaking  cyto-
chrome  C  of  human  glioma  cells  in  vitro  than  sin-
gle-walled CNT [57]. 
Zhang  and  coworkers  [58]  developed  a 
NGO-PEG-DOX for the anti-tumor effect in vitro and 
in  vivo  by  combination  of  photothermal-  and 
chemo-therapies.  The  experiment  revealed  that  the 
combined  chemo-photothermal  therapy  exhibited 
synergistic  effect  that  leads  to  better  cancer  killing 
effect  than  chemotherapy  or  photothermal  therapy 
alone.  
Cui and his coworkers [59] reported application 
of folic acid and sulfonic acid conjugated GO loaded 
with porphyrin photosensitizers for targeting photo-
dynamic therapy (PDT). PDT is a novel and efficient 
technique to treat diseases including cancers in clini-
cal  practice  because  of  its  attractive  traits  [60]  with 
low  toxicity  and  high  stability  under  physiological 
conditions. In their experiment, GO was loaded with a 
Chlorin  e6  photosensitizer  with  high  efficiency  via 
hydrophobic interactions and π-π stacking. Such sys-
tem, significantly increases the accumulation of pho-
tosensitizers in tumor cells, leading to a remarkable 
concentration-depended  photodynamic  effect  on 
cancer cells under irradiation. 
Liu  and  colleagues  [61]  further  studied  photo-
thermally assisted PDT using GO loaded with a pho-
tosensitizer, Chlorine e6, and demonstrated that such 
combined  treatment  yields  remarkably  improved 
cancer killing effect.  
In  summary,  the  structural  features  and  facile 
chemical processing and modification of GO provide 
fascinating opportunities for loading and delivery of a 
variety of molecules, from chemical drugs, genes, and 
photosensitizers,  and  beyond,  for  cancer  and  other 
disease treatment. The research in this area so far is 
encouraging, but far from mature, more exciting ac-
complishments will be made, moving forward toward 
the eventual clinical use.  
3. Biosensing and Bioimaging 
3.1 Biosensing 
Graphene  derivatives,  including  pristine  gra-
phene,  GO,  chemically  reduced  GO  (rGO)  [62]  and 
doped  graphene  [63]  have  been  intensively  studied 
for their widespread  applications in biosensing and 
detection of biomolecules such as thrombin [64], ATP 
[65], oligonucleotide [66], amino acid [67], and dopa-
mine [68]. Several types of GO-based biosensors have 
been  built,  which  include:  (1)  Making  use  of  super 
efficient fluorescence quenching ability of graphene, 
some  novel  fluorescence  resonance  energy  transfer 
(FRET)  based  biosensors  have  been  developed 
[64,65,69]; (2) Based on the unique electronic property 
of  graphene,  FET  type  biosensors  have  been  made 
[70];  (3)  Controllable  self-assembling  of  gra-
phene-biomolecules allows to build highly ultrasensi-
tive biosensors for detection of DNA and other mol-
ecules  [66,71-73];  (4)  As  a  matrix  for  detection  of 
molecules,  graphene-based  nanoplatform  for  ma-
trix-assisted laser desorption/ionization time-of-ﬂight 
mass  spectrometry  (MALDI-TOF  MS)  has  been  re-
ported [67,74]; and (5) GO-based novel biosensors via Theranostics 2012, 2(3) 
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electrochemical  principle  have  been  constructed  by 
taking  use  of  its  huge  surface  area,  good  electrical 
conductivity, and excellent capability of loading var-
ious  biomolecules  via  chemical  or  physical  interac-
tions  [68,75].  All  of  these have  been  thoroughly  re-
viewed by Li, Lin and colleagues [18], Jiang [20], and 
others [17,19,21,76]. Therefore we will not go into the 
details in this overview.  
3.2 Bioimaging 
Exploration  of  feasibilities  of  GO  in  biological 
imaging with optical and magnetic modalities has just 
started recently [19,26,33,77]. Dai et al. [26] for the first 
time examined cellular uptake of PEG-modified GO 
loaded  with  chemical  drugs  using  intrinsic  fluores-
cence of GO in the NIR region. Later, another group 
[78] studied gelatin-grafted rGO labeled with a fluo-
rescence dye for cellular imaging and drug delivery.  
Recently  researchers  have  begun  to  prepare 
smaller GO (with a size of 10 nm or less), often re-
ferred  to  as  graphene  quantum  dots  (GQDs),  from 
chemical oxidation of graphite [79-81] and “bottom up” 
approach [82]. These GQDs exhibit intrinsic fluores-
cence, and can be used for bioimaging purpose. Pan et 
al. [79] synthesized GQDs with blue emission color 
through  hydrothermal  cutting  of  GO.  These 
as-obtained GQDs are weakly fluorescent (quantum 
yield less than 10%), much lower than conventional 
organic dyes and II-VI type QDs, which hampers their 
practical  bioimaging  applications.  To  overcome  this 
problem, Eda et al. [80]  treated the chemically pro-
duced GQDs by a brief exposure to hydrazine vapor 
and  observed  significantly  improved  fluorescence. 
Surface  functionalization  of  GQD  with  alkylamine 
also gives rise to dramatically enhanced fluorescence 
[81]. Most recently, Zhu et al. [83] (Figure 5.) and our 
group [84] explored the possibility of GQDs for cel-
lular imaging. Compared with CdSe and other II-VI 
type  QDs,  GQDs  show  excellent  biocompatibility, 
physiological solubility, and low cytotoxicity, and can 
be used directly for intracellular imaging without the 
necessity for further surface processing or function-
alization.  In  addition,  GQDs  possess  unique  optical 
properties such as pH dependent and upconversion 
fluorescence  behaviors  [85].  The  upconversion  fluo-
rescence property of GQDs allows them to be excited 
at  NIR  region,  making  both  in  vitro  and  in  vivo 
bio-detection and imaging efficient, safe, and without 
interference  from  auto-fluorescence  from  the  cells, 
organs, or tissues in this region [86]. 
 
 
Figure 5. A. AFM image of the GQDs; B. Fluorescence spectra of aqueous solution of GQDs excited at 375 nm. Inset: aqueous solution 
of GQDs under UV light; C. cellular imaging of GQDs imaged under 405 nm; D. Cytoxicity of GQDs. [83] Reproduced by permission of 
The Royal Society of Chemistry. 
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Like  fluorescence  imaging  technique,  magnetic 
resonance  imaging  (MRI)  is  widely  used  in  clinical 
practice [87,88]. Recently our group [33] reported the 
synthesis of composites of dextran-coated Fe3O4 na-
noparticles (NPs) and GO (Fe3O4-GO) as T2-weighted 
contrast  agent  for  efficient  cellular  MRI.  The 
Fe3O4-GO  composites  we  prepared  possess  good 
physiological  stability  and  low  cytotoxicity.  Com-
pared  with  the  isolated  Fe3O4  NPs,  the  Fe3O4-GO 
composites  exhibit  significantly  enhanced  cellular 
MRI, able to detect cells at iron concentration of 5 µg 
mL-1 with cell density of 2 × 105 cells mL-1, and at the 
iron concentration of 20 µg mL-1 with cell density of 
1000 cells mL-1. 
 
 
Figure 6. Schematic illustration of preparation of the Fe3O4-GO composites and T2 weighted cellurlar MR images: (a) HeLa cells (2×105 
cells mL-1) incubated with the Fe3O4-GO composites at different concentrations. (b) Fe3O4-GO composites (20 μg Fe mL-1) incubated 
with HeLa cells at different cell density which Fe3O4 NPs formed aggregations on the GO sheets, resulting in a considerable enhanced T2 
relaxivity. [33] Reprinted with permission from ref.33. Copyright 2011 American Chemical Society. 
 
4. Other applications 
4.1 GO-based antibacterial materials.  
Fan et al. [89] prepared macroscopic freestand-
ing  GO  and  rGO  paper  from  their  suspension  by 
vacuum  filtration  technique,  and  found  that  these 
papers exhibit strong antibacterial effect. Considering 
the  scalability  and  low  cost  of  the  graphene-based 
antibacterial paper, this work opens new opportuni-
ties for the use of GO in environmental and clinical 
applications. 
Later  Akhavan  et  al.  [90]  investigated  an-
ti-bacterial effect of graphene nanosheets in the form 
of  nanowalls  deposited  on  stainless  steel  substrates 
for both Gram-positive and Gram-negative models of 
bacteria. It is interesting that the Gram-negative Esch-
erichia  coli  bacteria  with  an  outer  membrane  were 
more resistant to the cell membrane damage caused 
by  the  nanowalls  than  the  Gram-positive  Staphylo-
coccus aureus lacking the outer membrane. Moreover, 
the  rGO  nanowalls  were  more  toxic  to  the  bacteria 
than the GO nanowalls. The better antibacterial activ-
ity of the rGO nanowalls, according to the researchers, 
is due to the better charge transfer between the bacte-
ria and the more sharpened edges of the rGO nan-
owalls, during the contact interaction. 
Liu et al. [91] further probed the mechanism of 
antibacterial effect of 4 types of graphene derivatives, 
graphite  (Gt),  graphite  oxide  (GtO),  GO,  and  rGO. 
They found that the antibacterial activities decrease in 
the order of GO, rGO, Gt, and GtO. They assign the 
antibacterial effect to both membrane and oxidative 
stress, and then proposed a three-step mechanism for 
the  antibacterial  effect,  similar  to  that  of  carbon 
nanotube.  This  work  is  important  for  us  to  under-
stand  the  GO-bacteria  interaction  and  to  guide  de-
velopment  of  better  graphene-based  antibacterial 
materials.  
4.2 GO-based scaffold for cell culture.  
Min group studied the behavior of NIH-3T3 fi-Theranostics 2012, 2(3) 
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broblasts as a model of mammalian cells growing on a 
supported film of GO [92]. Their work suggests that 
GO film induces no significantly harmful effect on the 
mammalian  cells  with  respect  to  adhesion,  and  ex-
hibits  remarkably  high  gene  transfection  efficiency, 
250% that of cells grown on a cover glass substrate. 
The result indicated the potential application of GO as 
a surface coating material for implant.  
A graphene/chitosan film produced by solution 
casting method has also been investigated as scaffold 
materials in tissue engineering [8]. The work indicates 
that  the  graphene-based  film  does  not  hamper  the 
proliferation  of  human  mesenchymal  stem  cells 
(hMSCs). Instead, it accelerates their specific differen-
tiation into bone cells in a controlled manner through 
the  use  of  growth  factors  and  osteogenic  inducers, 
suggesting  the  potential  use  for  proliferation  and 
transplantation of stem cells and their specific differ-
entiation into muscles, bones, and cartilages for bone 
regeneration therapy [93] (Figure 7). Another study 
[94] revealed that chemical vapor deposition (CVD) 
grown  graphene  substrate  is  biocompatible  for  hu-
man  osteoblasts  as  well  as  for  hMSCs  with  higher 
proliferation of cell, compared to SiO2 substrate, and 
stimulates the growth and differentiation of cells. 
 
 
 
Figure 7. Graphene substrate for osteogenic differentiation. A. Optical image of graphene-coated Si/SiO2 chip, showing the graphene 
boundary. B. Osteocalcin (OCN) marker showing bone cell formation on the same chip only on the graphene-coated area; C-D. Alizarin 
red quantification deriving from hMSCs grown for 15 days on substrates with/without graphene as well as with/ without BMP-2. E-H. PET 
substrate stained with alizarin red showing calcium deposits due to osteogenesis. [93] Reprinted with permission from ref.93. Copyright 
2011 American Chemical Society. 
 
 
Inspired  by  the  work  mentioned  above,  Tang 
and  Cheng  et  al  [95]  investigated  CVD-grown  gra-
phene film as a substrate of neurites, one of the key 
structures  for  neural  functions  during  the  develop-
ment in a mouse hippocampal culture model. Their 
results  indicate  that  the  neurite  numbers  average 
length on graphene film were significantly enhanced 
during 2-7 days after cell seeding compared with tis-
sue culture polystyrene (TCPS) substrates. Moreover, 
GAP-43 expression was greatly enhanced in graphene 
group  compared  to  TCPS  group,  due  likely  to  the 
boost of neurite sprouting and outgrowth. This study 
suggests the potential application of pristine graphene 
as a novel material for neural interfacing. 
The interesting yet preliminary work described 
above suggests the potential applications of graphene 
as  antibacterial  materials  and  scaffold  materials  for 
cell culture.  Theranostics 2012, 2(3) 
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5. Conclusions and perspectives 
As  in  many  other  fields,  the  research  on  bio-
medical applications of graphene has seen dramatic 
progress, and is expanding rapidly, yet mostly in its 
initial stage. The advances made in this area so far are 
exciting  and  encouraging,  the  challenges  we  face, 
however, are also very huge and must be overcome. 
One  of  such  challenges  is  thorough  and  profound 
understanding of graphene-cell (or tissue, organ) in-
teractions, especially the cellular uptake mechanism. 
Such knowledge certainly facilitates development of 
more  efficient  graphene  or  GO-based  nanoplatform 
for drug delivery, biosensing and other applications, 
which, however, is still lacking at the moment. The 
toxicity of graphene and GO, at in vitro and in vivo 
level, is another major concern. At the current stage 
there  are  only  a  few  publications  in  this  regard 
[96-102].  The  preliminary  results  indicate  that  the 
physicochemical  properties  such  as  flat  shape  and 
charges,  are  closely  related  to  the  cytotoxicity,  and 
affect in vivo biodistribution and fate of GO [17]. The 
mechanisms  of  the  in  vitro  biotoxicity  caused  by 
graphene are related to oxidative stress and damage 
of  cell  membrane.  Clearly,  a  systematic  study  is 
highly desired to address the safety concerns before 
practical applications of graphene in biomedicine. 
 The  current  research  on  delivery  of  drugs, 
genes,  we  expect,  will  extend  to  that  of  proteins, 
growth factors, and other biomolecules, either single 
or combined use of the aforementioned biomolecules, 
for  cancer  and  other  disease  therapies.  Given  its 
structural  features  and  exceptional  physicochemical 
properties,  design  and  construction  of  GO-based 
theranostic  platform  with  multifunctionalities  and 
multimodalities  is  a  new  direction  to  pursue.  Defi-
nitely,  these  goals can  only be reached by the  joint 
efforts  from  chemistry,  biomedicine,  materials  sci-
ences, and nanotechnology. To this end, development 
of  suitable  chemical  synthesis  and  functionalization 
approaches for precise control over size, size distri-
bution,  morphology,  structural  defects,  and  oxy-
gen-containing groups of GO is urgently needed, as 
this  is  closely  correlated  to  the  performance  of  the 
GO-based nanomaterials for biomedical applications, 
and the safety issues as well.  
For GO-based biosensing based on FRET princi-
ple, tuning electronic property of GO by controllable 
modification  and  reduction  of  originally  prepared 
GO, and development of techniques to integrate GO 
into  practical  devices  having  high  sensitivity,  selec-
tivity with acceptable reproducibility, reliability and 
low cost remain a big challenge. As for GO-based bi-
oimaging,  although  the  GQDs  have  distinct  ad-
vantages over II-IV QDs in their intrinsic biocompati-
bility,  safety  and  facile  functionalization,  the  weak 
fluorescence  intensity  (with  quantum  yield  about 
10%) and broad emission band (with bandwidth be-
yond 100 nm) are certainly major obstacles for their 
use in biodetection and labeling, so more efforts must 
be paid to prepare GQDs with a good control of size 
and  size  distribution,  the  surface  defects,  and  their 
functionalization,  to  improve  fluorescence  quantum 
yield and other important properties.  
 The  research  on  graphene/GO-based  scaffold 
materials for cell culture is a relatively new direction 
that deserves special attention. The study in this field 
so far demonstrated that graphene and GO are able to 
accelerate the growth, differentiation, and prolifera-
tion of stem cells, and therefore hold great promise in 
tissue engineering, regenerative medicine, and other 
biomedical fields.  
We  have  selectively  reviewed  the  surprisingly 
rapid and exciting advances in the biomedical appli-
cations of graphene with focus on drug delivery and 
bioimaging, made in the last few years. This trend, we 
believe, will continue and even speed up in the years 
to come. 
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